SLEEP & RECOVERY / COLOPHON
About This Reading Desk
An independent, citation-anchored digest of the nootropic-peptide literature. Not a vendor. Not a clinic. Not medical advice.
What Peptide Ways is
Peptide Ways is an independent editorial reference desk covering the published research on two peptides studied through the lens of sleep and recovery: DSIP (Delta Sleep-Inducing Peptide) and Selank, with DSIP as the lead. The site exists to make a scattered, sometimes overstated, and genuinely uncertain literature legible — to tell a reader, in plain language and with citations, what each compound was actually tested on, in which species, and how far that evidence reaches.
The organizing frame is sleep and anxiety as two sides of the same recovery question: DSIP approaches it directly (a sleep signal, however inconsistent) while Selank approaches it through anxiety relief (quieting the arousal that interferes with sleep and recovery). Reading them together is more useful than reading either in isolation, because their gaps complement each other — and because both illustrate, in very different ways, how early the science still is.
Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every cited source.
How it is compiled
Three principles govern what appears on this site.
First, everything is anchored to the peer-reviewed literature. Every research claim is tied to a numbered citation — PubMed-indexed journal articles, clinical studies, and peer-reviewed reviews, with DOIs or PubMed links — collected on the references page. Where a finding comes from a review rather than a primary study, the review is cited as such, and the distinction is flagged where it matters.
Second, the evidence is reported at its actual strength. Where study populations were small, findings were not replicated, or the evidence comes from a single geographic cluster of researchers, the page says so explicitly. DSIP's "extremely poorly documented" sleep evidence [2] and Selank's single-region clinical base [8] are stated plainly because the reader deserves an accurate map, not a promotional summary.
Third, community experience is reported as what it is. For compounds used in self-experimentation, forum and community accounts carry real information — about what people actually experience, including non-response and adverse effects — but they are consistently labeled as anecdotal, not clinical evidence, and never presented alongside cited findings as equivalent data.
What it is not
Peptide Ways is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person, and it never frames an animal-study dose as something a human should take.
The peptides discussed here are research compounds. Neither is an approved medicine for human use in the United States or the European Union. Both are sold under research-chemical designations that carry no quality guarantee outside pharmaceutical manufacturing. Readers with persistent sleep problems, significant anxiety, or any medical concern should consult a licensed clinician operating within their own jurisdiction, working with regulated and evidence-based options. The value this site offers is a calm, accurate account of what the literature actually says — nothing more than that.